Pay in 4 interest-free payments of $5.95 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
Human Intestinal Enteroids With Inducible Neurogenin-3 Expression as a Novel Model of Gut Hormone Secretion
Revisiting the 6-month BT-first recommendation Clinical practice guidelines have evolved towards a complications-centric approach to obesity management, yet outdated recommendations regarding intervention timing persist
Medication Cost Varies Medication cost depends on the medication, dose, insurance coverage, pharmacy, and availability
10.1002/advs.201900752 198 HuW.KongX.WangH.LiY.LuoY
Crockett Chair in Diabetes Research, medical director of AdventHealth Diabetes Institute and a Healio | Endocrine Today Co-editor, described the FLOW findings as practice changing. Pratley said while the American Diabetes Association Standards of Care recommends SGLT2 inhibitors as the first-line treatment for most adults with type 2 diabetes and CKD, the FLOW trial may change that in the future
US$ 23.79
US$ 28.44
US$ 25.41
US$ 24.49
US$ 28.95
US$ 27.38
US$ 29.47
US$ 21.30
US$ 22.93
US$ 20.01
